Temozolomide: A Viewpoint by Henry S. Friedman

ISSN： 1172-7047

Source： CNS Drugs, Vol.12, Iss.3, 1999-09, pp. : 244-245

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Airmax: A Viewpoint by Henry Chrystyn

By Chrystyn H.

Drugs, Vol. 62, Iss. 13, 2002-01 ,pp. : 1896-1897

Adis International

Access to resources Recommend Favorite

Temozolomide

By Hvizdos K.M. Goa K.L.

CNS Drugs, Vol. 12, Iss. 3, 1999-09 ,pp. : 237-243

Adis International

Access to resources Recommend Favorite

Rotavirus Vaccine (RotaTeq®): A Viewpoint by Henry R. Shinefield

By Shinefield Henry R.

Pediatric Drugs, Vol. 8, Iss. 3, 2006-01 ,pp. : 203-204

Adis International

Access to resources Recommend Favorite

Ezetimibe: A Viewpoint by Anthony S. Wierzbicki

By Wierzbicki A.S.

American Journal of Cardiovascular Drugs, Vol. 3, Iss. 1, 2003-01 ,pp. : 77-78

Adis International

Access to resources Recommend Favorite

Telithromycin: A Viewpoint by S. Ragnar Norrby

By Norrby S.R.

Drugs, Vol. 61, Iss. 6, 2001-01 ,pp. : 830-831

Adis International

Access to resources Recommend Favorite